Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Effect of A Sun Protection Intervention on the Immune Response to Measles Booster Vaccination in Infants in Rural South Africa

dc.contributor.authorWright, Caradee Y.
dc.contributor.authorLucas, Robyn
dc.contributor.authorD'Este, Catherine
dc.contributor.authorKapwata, T.
dc.contributor.authorKunene, Zamantimande
dc.contributor.authorSwaminathan, Ashwin
dc.contributor.authorMathee, Angela
dc.contributor.authorAlbers, Patricia N.
dc.date.accessioned2019-04-12T08:39:57Z
dc.date.available2019-04-12T08:39:57Z
dc.date.issued2018
dc.date.updated2019-03-12T07:24:41Z
dc.description.abstractThe incidence of many serious childhood infections can be reduced by vaccination. High sun exposure at the time of vaccination has been associated with a reduced antigen‐specific immune response. We hypothesized that providing sun protection advice and equipment to mothers of children who were waiting to be vaccinated would result in a more robust immunization response. We conducted a pilot study in 2015/2016 (data analyzed in 2017–2018) among 98 Black African children (~18 months of age) receiving the booster measles vaccination at two clinics in South Africa. Clinics were randomized to receive (or not) sun protection advice and equipment. We recorded demographic information on children and mothers and data on the child's usual sun exposure. At approximately 4 weeks’ postmeasles vaccination, we measured measles immunoglobulin G levels in children. All children with blood results (n = 87, 89%) across both groups had antibody titers higher than 200 mIU mL−1 which was considered the protective antibody concentration. There was no statistically significant difference in titers between groups: geometric difference in mean titers 1.13 mIU mL−1 (95% CI 0.85, 1.51; P = 0.39) and 1.38 mIU mL−1 (95% CI 0.90, 2.11, P = 0.14) for unadjusted and adjusted analyses, respectively. This study demonstrated that a sun protection intervention study could be performed in a developing‐world pediatric vaccination setting. Although the sun protection intervention around the time of vaccination was not associated with a higher antibody level, given the potential importance of such an effect, a larger study should be considered.en_AU
dc.description.sponsorshipThis work was supported by funding from the National Research Foundation (NRF) of South Africa (Grant number: 93426) and the South African Medical Research Council (SAMRC) Heat and Health Flagship Seed project
dc.format.mimetypeapplication/pdfen_AU
dc.identifier.issn0031-8655en_AU
dc.identifier.urihttp://hdl.handle.net/1885/159533
dc.language.isoen_AUen_AU
dc.publisherAmerican Society of Photobiologyen_AU
dc.rights© 2018 The American Society of Photobiology
dc.sourcePhotochemistry and Photobiologyen_AU
dc.titleEffect of A Sun Protection Intervention on the Immune Response to Measles Booster Vaccination in Infants in Rural South Africaen_AU
dc.typeJournal articleen_AU
local.bibliographicCitation.issue1en_AU
local.contributor.affiliationWright, Caradee Y., South African Medical Research Council and University of Pretoria, Pretoria, South Africaen_AU
local.contributor.affiliationLucas, Robyn, College of Health and Medicine, ANUen_AU
local.contributor.affiliationD'Este, Catherine, College of Health and Medicine, ANUen_AU
local.contributor.affiliationKapwata, T., Environment and Health Research Unit, South African Medical Research Councilen_AU
local.contributor.affiliationKunene, Zamantimande, South African Medical Research Council, Johannesburg, South Africaen_AU
local.contributor.affiliationSwaminathan, Ashwin, The Canberra Hospitalen_AU
local.contributor.affiliationMathee, Angela, South African Medical Research Council, Johannesburg, South Africaen_AU
local.contributor.affiliationAlbers, Patricia N., South African Medical Research Councilen_AU
local.contributor.authoruidLucas, Robyn, u4002313en_AU
local.contributor.authoruidD'Este, Catherine, u5460340en_AU
local.description.embargo2037-12-31
local.description.notesImported from ARIESen_AU
local.identifier.absfor110702 - Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)en_AU
local.identifier.absfor111704 - Community Child Healthen_AU
local.identifier.absfor111706 - Epidemiologyen_AU
local.identifier.absseo920205 - Health Education and Promotionen_AU
local.identifier.absseo920501 - Child Healthen_AU
local.identifier.absseo920108 - Immune System and Allergyen_AU
local.identifier.ariespublicationu1067127xPUB9en_AU
local.identifier.citationvolume95en_AU
local.identifier.doi10.1111/php.13004en_AU
local.identifier.scopusID2-s2.0-85054337340
local.type.statusPublished Versionen_AU

Downloads

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
php.13004.pdf
Size:
323.49 KB
Format:
Adobe Portable Document Format
abcd